| Mucosal healing in inflammatory bowel disease: results from a Norwegian population-based cohort KF Frøslie, J Jahnsen, BA Moum, MH Vatn, IBSEN Group Gastroenterology 133 (2), 412-422, 2007 | 1322 | 2007 |
| Switching from originator infliximab to biosimilar CT-P13 compared with maintained treatment with originator infliximab (NOR-SWITCH): a 52-week, randomised, double-blind, non … KK Jørgensen, IC Olsen, GL Goll, M Lorentzen, N Bolstad, ... The Lancet 389 (10086), 2304-2316, 2017 | 905 | 2017 |
| Clinical course during the first 10 years of ulcerative colitis: results from a population-based inception cohort (IBSEN Study) IC Solberg, I Lygren, J Jahnsen, E Aadland, O Høie, M Cvancarova, ... Scandinavian journal of gastroenterology 44 (4), 431-440, 2009 | 887 | 2009 |
| Clinical course in Crohn’s disease: results of a Norwegian population-based ten-year follow-up study IC Solberg, MH Vatn, O Høie, N Stray, J Sauar, J Jahnsen, B Moum, ... Clinical Gastroenterology and Hepatology 5 (12), 1430-1438, 2007 | 853 | 2007 |
| Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a Norwegian population KM Boberg, E Aadland, J Jahnsen, N Raknerud, M Stiris, H Bell Scandinavian journal of gastroenterology 33 (1), 99-103, 1998 | 647 | 1998 |
| Gluten induces an intestinal cytokine response strongly dominated by interferon gamma in patients with celiac disease EM Nilsen, FL Jahnsen, KEA Lundin, FE Johansen, O Fausa, LM Sollid, ... Gastroenterology 115 (3), 551-563, 1998 | 564 | 1998 |
| Association of NOD2 (CARD 15) genotype with clinical course of Crohn's disease: a cohort study J Hampe, J Grebe, S Nikolaus, C Solberg, PJP Croucher, S Mascheretti, ... The Lancet 359 (9318), 1661-1665, 2002 | 544 | 2002 |
| Assessment of disease activity in ulcerative colitis by faecal calprotectin, a novel granulocyte marker protein AG Røseth, E Aadland, J Jahnsen, N Raknerud Digestion 58 (2), 176-180, 1997 | 513 | 1997 |
| C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study M Henriksen, J Jahnsen, I Lygren, N Stray, J Sauar, MH Vatn, B Moum, ... Gut 57 (11), 1518-1523, 2008 | 511 | 2008 |
| Ulcerative colitis and clinical course: results of a 5-year population-based follow-up study (the IBSEN study) M Henriksen, J Jahnsen, I Lygren, J Sauar, ϕystein Kjellevold, T Schulz, ... Inflammatory bowel diseases 12 (7), 543-550, 2006 | 349 | 2006 |
| Bone mineral density is reduced in patients with Crohn's disease but not in patients with ulcerative colitis: a population based study. J Jahnsen, JA Falch, E Aadland, P Mowinckel Gut 40 (3), 313-319, 1997 | 339 | 1997 |
| Vitamin D status, parathyroid hormone and bone mineral density in patients with inflammatory bowel disease J Jahnsen, JA Falch, P Mowinckel, E Aadland Scandinavian journal of gastroenterology 37 (2), 192-199, 2002 | 272 | 2002 |
| Relationship between sick leave, unemployment, disability, and health-related quality of life in patients with inflammatory bowel disease T Bernklev, J Jahnsen, M Henriksen, I Lygren, E Aadland, J Sauar, ... Inflammatory bowel diseases 12 (5), 402-412, 2006 | 270 | 2006 |
| Health-related quality of life in patients with inflammatory bowel disease measured with the short form-36: psychometric assessments and a comparison with general population norms T Bernklev, J Jahnsen, I Lygren, M Henriksen, M Vatn, B Moum Inflammatory bowel diseases 11 (10), 909-918, 2005 | 264 | 2005 |
| Clinical course in Crohn's disease: results of a five-year population-based follow-up study (the IBSEN study) M Henriksen, J Jahnsen, I Lygren, E Aadland, T Schulz, MH Vatn, ... Scandinavian journal of gastroenterology 42 (5), 602-610, 2007 | 243 | 2007 |
| Consecutive fecal calprotectin measurements to predict relapse in patients with ulcerative colitis receiving infliximab maintenance therapy MD Vos, EJ Louis, J Jahnsen, JGP Vandervoort, M Noman, O Dewit, ... Inflammatory bowel diseases 19 (10), 2111-2117, 2013 | 238 | 2013 |
| Integrative epigenome-wide analysis demonstrates that DNA methylation may mediate genetic risk in inflammatory bowel disease NT Ventham, NA Kennedy, AT Adams, R Kalla, S Heath, KR O'leary, ... Nature communications 7 (1), 13507, 2016 | 222 | 2016 |
| Prevalence of sclerosing cholangitis detected by magnetic resonance cholangiography in patients with long-term inflammatory bowel disease AK Lunder, JR Hov, A Borthne, J Gleditsch, G Johannesen, K Tveit, ... Gastroenterology 151 (4), 660-669. e4, 2016 | 222 | 2016 |
| Body composition in patients with inflammatory bowel disease: a population-based study J Jahnsen, JA Falch, P Mowinckel, E Aadland Official journal of the American College of Gastroenterology| ACG 98 (7 …, 2003 | 208 | 2003 |
| Health‐related quality of life in patients with inflammatory bowel disease five years after the initial diagnosis T Bernklev, J Jahnsen, E Aadland, J Sauar, T Schulz, I Lygren, ... Scandinavian journal of gastroenterology 39 (4), 365-373, 2004 | 188 | 2004 |
